Results 251 to 260 of about 2,408,361 (302)

Correction: Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder

Neurology and Therapy
Stacey L. Clardy, Sean J. Pittock, Orhan Aktas, Jin Nakahara, Noriko Isobe, Diego Centonze, Sami Fam, Adrian Kielhorn, Jeffrey C. Yu, Jeroen Jansen, Ina Zhang   +10 more
doaj   +1 more source

AI-driven enhancements in rare disease diagnosis and support system optimization. [PDF]

Intractable Rare Dis Res
Wang X, He D, Jin C.
europepmc   +1 more source

Landscape of parental postzygotic mutations in >11,000 rare disease trios

Garcia-Salinas OI, Sanghvi R, Sayer JA, Benach MTI, Pham MH, Scally A, Martin HC, Rahbari R.   +7 more
europepmc   +1 more source

Facilitating Expedited Drug Approval—the Past, Present, and Future of Clinical Trials for Pediatric Rheumatic Disease

Arthritis Care &Research, EarlyView.
Pamela F. Weiss, Hermine I. Brunner
wiley   +1 more source

From system building to global engagement: Current significance of and future directions for rare disease research in China. [PDF]

Intractable Rare Dis Res
Tang W.
europepmc   +1 more source

Caspase-8, association with Alzheimer\u27s disease and functional analysis of rare variants [PDF]

, 2017
Cruchaga, Carlos, et al.,, Lord, Jenny
core   +1 more source

Population Physiologically-Based Pharmacokinetic Modeling to Determine Ontogeny: A Quantitative Clinical Pharmacology Example in Pediatric Rare Disease. [PDF]

CPT Pharmacometrics Syst Pharmacol
Cleary Y, Prasad B, Ogungbenro K, Gertz M, Galetin A.   +4 more
europepmc   +1 more source

Rare Disease Drug Repurposing.

JAMA Netw Open
Nijim S, Korsunska A, Zinski J, Bolden SE, Zuccato M, Repasky M, Fajgenbaum DC.   +6 more
europepmc   +1 more source